Published in:
01-08-2011 | Letter
Response to 'Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study'
Authors:
Kazuki Yoshida, Kazuo Matsui, Hiroto Nakano, Hideto Oshikawa, Masako Utsunomiya, Tatsuo Kobayashi, Makiko Kimura, Gautam A Deshpande, Mitsumasa Kishimoto
Published in:
Arthritis Research & Therapy
|
Issue 4/2011
Login to get access
Excerpt
We read with interest the report by Lee and colleagues in the June issue of
Arthritis Research & Therapy [
1]. The study compared the Disease Activity Score in 28 joints calculated by using C-reactive protein (DAS28-CRP) versus American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) remission in terms of residual pain. The authors stated that DAS28-CRP remission criteria allowed for persistence of pain in more than 10% of patients, whereas there were very few complaints of pain among patients in ACR/EULAR remission. This is a very important finding as it clearly demonstrated incompetence of the DAS28-CRP remission criteria in defining remission that is meaningful for patients, thus encouraging transition to new ACR/EULAR remission criteria. …
